SEC FORM 4
$0.00
DiaMedica Therapeutics Inc. (DMAC)
Acquisition (code A) of 60,200 shares at $0 per share.
Reporting Person Pauls Dietrich John · Officer Title President & CEO · Transaction Code A
Traded Aug 10, 2026 · Disclosed Aug 12, 2026
Source: SEC Form 4 · 0001760123-26-000004 · filed 2026-08-12 · View filing →